-
Something wrong with this record ?
Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters
B. Nieuwenhuis, B. Haenzi, S. Hilton, A. Carnicer-Lombarte, B. Hobo, J. Verhaagen, JW. Fawcett
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
MR/R004463/1
Medical Research Council - United Kingdom
MR/R004544/1
Medical Research Council - United Kingdom
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Open Access Digital Library
from 1997-01-01
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Dependovirus * genetics MeSH
- Genetic Vectors genetics MeSH
- Rats MeSH
- Mice MeSH
- Promoter Regions, Genetic MeSH
- Pyramidal Tracts * MeSH
- Transduction, Genetic MeSH
- Transgenes MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Adeno-associated viral vectors are widely used as vehicles for gene transfer to the nervous system. The promoter and viral vector serotype are two key factors that determine the expression dynamics of the transgene. A previous comparative study has demonstrated that AAV1 displays efficient transduction of layer V corticospinal neurons, but the optimal promoter for transgene expression in corticospinal neurons has not been determined yet. In this paper, we report a side-by-side comparison between four commonly used promoters: the short CMV early enhancer/chicken β actin (sCAG), human cytomegalovirus (hCMV), mouse phosphoglycerate kinase (mPGK) and human synapsin (hSYN) promoter. Reporter constructs with each of these promoters were packaged in AAV1, and were injected in the sensorimotor cortex of rats and mice in order to transduce the corticospinal tract. Transgene expression levels and the cellular transduction profile were examined after 6 weeks. The AAV1 vectors harbouring the hCMV and sCAG promoters resulted in transgene expression in neurons, astrocytes and oligodendrocytes. The mPGK and hSYN promoters directed the strongest transgene expression. The mPGK promoter did drive expression in cortical neurons and oligodendrocytes, while transduction with AAV harbouring the hSYN promoter resulted in neuron-specific expression, including perineuronal net expressing interneurons and layer V corticospinal neurons. This promoter comparison study contributes to improve transgene delivery into the brain and spinal cord. The optimized transduction of the corticospinal tract will be beneficial for spinal cord injury research.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026119
- 003
- CZ-PrNML
- 005
- 20211026133207.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41434-020-0169-1 $2 doi
- 035 __
- $a (PubMed)32576975
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Nieuwenhuis, Bart $u John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. bn246@cam.ac.uk $u Laboratory for Regeneration of Sensorimotor Systems, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Meibergdreef 47, 1105 BA, Amsterdam, The Netherlands. bn246@cam.ac.uk
- 245 10
- $a Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters / $c B. Nieuwenhuis, B. Haenzi, S. Hilton, A. Carnicer-Lombarte, B. Hobo, J. Verhaagen, JW. Fawcett
- 520 9_
- $a Adeno-associated viral vectors are widely used as vehicles for gene transfer to the nervous system. The promoter and viral vector serotype are two key factors that determine the expression dynamics of the transgene. A previous comparative study has demonstrated that AAV1 displays efficient transduction of layer V corticospinal neurons, but the optimal promoter for transgene expression in corticospinal neurons has not been determined yet. In this paper, we report a side-by-side comparison between four commonly used promoters: the short CMV early enhancer/chicken β actin (sCAG), human cytomegalovirus (hCMV), mouse phosphoglycerate kinase (mPGK) and human synapsin (hSYN) promoter. Reporter constructs with each of these promoters were packaged in AAV1, and were injected in the sensorimotor cortex of rats and mice in order to transduce the corticospinal tract. Transgene expression levels and the cellular transduction profile were examined after 6 weeks. The AAV1 vectors harbouring the hCMV and sCAG promoters resulted in transgene expression in neurons, astrocytes and oligodendrocytes. The mPGK and hSYN promoters directed the strongest transgene expression. The mPGK promoter did drive expression in cortical neurons and oligodendrocytes, while transduction with AAV harbouring the hSYN promoter resulted in neuron-specific expression, including perineuronal net expressing interneurons and layer V corticospinal neurons. This promoter comparison study contributes to improve transgene delivery into the brain and spinal cord. The optimized transduction of the corticospinal tract will be beneficial for spinal cord injury research.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a Dependovirus $x genetika $7 D000229
- 650 _2
- $a genetické vektory $x genetika $7 D005822
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 12
- $a pyramidové dráhy $7 D011712
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a transdukce genetická $7 D014161
- 650 _2
- $a transgeny $7 D019076
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Haenzi, Barbara $u John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
- 700 1_
- $a Hilton, Sam $u John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
- 700 1_
- $a Carnicer-Lombarte, Alejandro $u John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK
- 700 1_
- $a Hobo, Barbara $u Laboratory for Regeneration of Sensorimotor Systems, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Meibergdreef 47, 1105 BA, Amsterdam, The Netherlands
- 700 1_
- $a Verhaagen, Joost $u Laboratory for Regeneration of Sensorimotor Systems, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), Meibergdreef 47, 1105 BA, Amsterdam, The Netherlands $u Centre for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
- 700 1_
- $a Fawcett, James W $u John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK $u Centre of Reconstructive Neuroscience, Institute of Experimental Medicine, Vídeňská 1083, 142 20, Prague 4, Czech Republic
- 773 0_
- $w MED00001890 $t Gene therapy $x 1476-5462 $g Roč. 28, č. 1-2 (2021), s. 56-74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32576975 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133213 $b ABA008
- 999 __
- $a ok $b bmc $g 1714975 $s 1146626
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 28 $c 1-2 $d 56-74 $e 20200623 $i 1476-5462 $m Gene therapy $n Gene Ther $x MED00001890
- GRA __
- $a MR/R004463/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/R004544/1 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20211013